Yusuke Tomita

4.3k total citations
98 papers, 2.8k citations indexed

About

Yusuke Tomita is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yusuke Tomita has authored 98 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Oncology, 34 papers in Molecular Biology and 31 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yusuke Tomita's work include Cancer Immunotherapy and Biomarkers (20 papers), Immunotherapy and Immune Responses (19 papers) and Lung Cancer Research Studies (16 papers). Yusuke Tomita is often cited by papers focused on Cancer Immunotherapy and Biomarkers (20 papers), Immunotherapy and Immune Responses (19 papers) and Lung Cancer Research Studies (16 papers). Yusuke Tomita collaborates with scholars based in Japan, United States and China. Yusuke Tomita's co-authors include Jane B. Trepel, Takuro Sakagami, Tokunori Ikeda, Sunmin Lee, Takashi Tsuji, Yasuhiro Tomooka, Kazuhisa Nakao, Kentaro Ishida, Masahiro Saitoh and Ritsuko Morita and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Yusuke Tomita

91 papers receiving 2.7k citations

Peers

Yusuke Tomita

ONCOL

IMMUN

PRM

NEURO

Aaron P. Rapoport United States

Sven Peine Germany

Hans Schlößer Germany

Stefano Volpi Italy

Shuang Qin China

Mauro Truini Italy

Keisuke Watanabe Japan

Gaia Goteri Italy

Joseph P. McGuirk United States

Aaron P. Rapoport United States

Yusuke Tomita

1.2k ×1.0

2.1k ×2.3

ONCOL

703 ×1.2

IMMUN

350 ×0.7

PRM

199 ×0.7

NEURO

Citations per year, relative to Yusuke Tomita Yusuke Tomita (= 1×) peers Aaron P. Rapoport

Countries citing papers authored by Yusuke Tomita

Since Specialization

Citations

This map shows the geographic impact of Yusuke Tomita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yusuke Tomita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yusuke Tomita more than expected).

Fields of papers citing papers by Yusuke Tomita

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yusuke Tomita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yusuke Tomita. The network helps show where Yusuke Tomita may publish in the future.

Co-authorship network of co-authors of Yusuke Tomita

This figure shows the co-authorship network connecting the top 25 collaborators of Yusuke Tomita. A scholar is included among the top collaborators of Yusuke Tomita based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yusuke Tomita. Yusuke Tomita is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hamada, Shohei, Kimitaka Akaike, Hiroko Okabayashi, et al.. (2024). The impact of factor Xa inhibitors on bleeding risk in patients with respiratory diseases. Scientific Reports. 14(1). 4039–4039. 1 indexed citations

Zhu, Lei, et al.. (2024). Circulating tumor cells are associated with lung cancer subtypes: a large-scale retrospective study. Translational Lung Cancer Research. 13(11). 3122–3138. 1 indexed citations

Tomita, Yusuke, et al.. (2023). A Unique Case of Intracranial Amelanotic Melanoma with BRAF V600E Mutation Successfully Treated via Molecular-targeted Therapy. NMC Case Report Journal. 10(0). 67–73. 2 indexed citations

Saruwatari, Koichi, et al.. (2022). Successful treatment with dupilumab for mucus plugs in severe asthma. SHILAP Revista de lepidopterología. 11(1). e01074–e01074. 11 indexed citations

Sato, Ryo, Takashi Semba, Yusuke Tomita, et al.. (2021). TGFβ Signaling Activated by Cancer-Associated Fibroblasts Determines the Histological Signature of Lung Adenocarcinoma. Cancer Research. 81(18). 4751–4765. 42 indexed citations

Carraway, Hetty E., Yazeed Sawalha, Ivana Gojo, et al.. (2021). Phase 1 study of the histone deacetylase inhibitor entinostat plus clofarabine for poor-risk Philadelphia chromosome-negative (newly diagnosed older adults or adults with relapsed refractory disease) acute lymphoblastic leukemia or biphenotypic leukemia. Leukemia Research. 110. 106707–106707. 10 indexed citations

Yang, Yongjie, Jingli Lü, Jian Kang, et al.. (2021). Evaluation of the reporting quality of clinical practice guidelines on lung cancer using the RIGHT checklist. Translational Lung Cancer Research. 10(6). 2588–2602. 7 indexed citations

Tomita, Yusuke, Tokunori Ikeda, Shinya Sakata, et al.. (2020). Association of Probiotic Clostridium butyricum Therapy with Survival and Response to Immune Checkpoint Blockade in Patients with Lung Cancer. Cancer Immunology Research. 8(10). 1236–1242. 161 indexed citations

Kashiwabara, Kosuke, Yusuke Tomita, Sho Saeki, et al.. (2018). Lung abscess following bronchoscopy due to multidrug-resistant Capnocytophaga sputigena adjacent to lung cancer with high PD-L1 expression. Journal of Infection and Chemotherapy. 24(10). 852–855. 10 indexed citations

10.

Sakata, Shinya, Sho Saeki, Yoshihiko Sakata, et al.. (2018). The impact of continuing ALK inhibitors beyond initial disease progression on clinical outcome in patients with advanced ALK-positive non-small cell lung cancer: Results of a multicenter retrospective analysis. Annals of Oncology. 29. ix163–ix163. 1 indexed citations

11.

Duffy, Austin G., Chi Ma, Susanna V. Ulahannan, et al.. (2017). Phase I and Preliminary Phase II Study of TRC105 in Combination with Sorafenib in Hepatocellular Carcinoma. Clinical Cancer Research. 23(16). 4633–4641. 68 indexed citations

12.

Ogawa, Mikako, Yusuke Tomita, Yuko Nakamura, et al.. (2017). Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunity. Oncotarget. 8(6). 10425–10436. 195 indexed citations

13.

Yuno, Akira, et al.. (2017). Clinical Evaluation and Biomarker Profiling of Hsp90 Inhibitors. Methods in molecular biology. 1709. 423–441. 97 indexed citations

14.

Tomita, Yusuke, Naoki Saita, K Konno, et al.. (2016). Emerging ST121/ agr 4 community-associated methicillin-resistant Staphylococcus aureus (MRSA) with strong adhesin and cytolytic activities: trigger for MRSA pneumonia and fatal aspiration pneumonia in an influenza-infected elderly. New Microbes and New Infections. 13. 17–21. 7 indexed citations

15.

Goey, Andrew K.L., Tristan M. Sissung, Cody J. Peer, et al.. (2015). Effects of UGT1A1 genotype on the pharmacokinetics, pharmacodynamics, and toxicities of belinostat administered by 48‐hour continuous infusion in patients with cancer. The Journal of Clinical Pharmacology. 56(4). 461–473. 25 indexed citations

16.

Thomas, Anish, Arun Rajan, Arlene Berman, et al.. (2015). Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial. The Lancet Oncology. 16(2). 177–186. 197 indexed citations

17.

Thomas, Anish, Arun Rajan, Éva Szabó, et al.. (2014). A Phase I/II Trial of Belinostat in Combination with Cisplatin, Doxorubicin, and Cyclophosphamide in Thymic Epithelial Tumors: A Clinical and Translational Study. Clinical Cancer Research. 20(21). 5392–5402. 79 indexed citations

18.

Tomita, Yusuke, Akira Yuno, Hirotake Tsukamoto, et al.. (2013). Identification of Promiscuous KIF20A Long Peptides Bearing Both CD4+ and CD8+ T-cell Epitopes: KIF20A-Specific CD4+ T-cell Immunity in Patients with Malignant Tumor. Clinical Cancer Research. 19(16). 4508–4520. 50 indexed citations

19.

Tomita, Yusuke, Katsunori Imai, Satoru Senju, et al.. (2011). A novel tumor‐associated antigen, cell division cycle 45‐like can induce cytotoxic T‐lymphocytes reactive to tumor cells. Cancer Science. 102(4). 697–705. 33 indexed citations

20.

Tomita, Yusuke, Michiko Harao, Satoru Senju, et al.. (2010). Peptides derived from human insulin‐like growth factor‐II mRNA binding protein 3 can induce human leukocyte antigen‐A2‐restricted cytotoxic T lymphocytes reactive to cancer cells. Cancer Science. 102(1). 71–78. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact